SILVER SPRING, Md.,
May 6, 2014 /PRNewswire/
-- Pharmagen, Inc. (OTCPINK: PHRX) (the "Company" or
"Pharmagen") today announced that Frederick
W. Mundt has accepted the position of Senior Vice President
of Sales. Frederick ("Fred") begin on May 2, 2014. Fred's addition is key to
building out the Pharmagen Team. Fred brings a wealth of
knowledge and experience in sales, business development and
operational leadership. Highlights of Fred's experience
includes: nine years with Astellas Pharmaceuticals, ten years with
Ortho Biotech Inc., and most recently he served as Director,
Commercial Deployment and Alignments with Quest Diagnostics.
"Fred's rich experience in direct sales organizations as well as
his most recent role at Quest Diagnostics where he was integral in
building out their sales capacity and processes made Fred the clear
leader amongst a strong talent pool provided by Tim Tolan, Senior Partner at Sandford Rose
Associates – The Toland Group. We conducted an intricate
selection process and Fred's skills and professionalism, especially
his detailed understanding in how to build a sales organization
were the determinate factors in his selection," says Boyd Relac, Chief Operating Officer. Relac
continued, "We have a plan built for Fred to hit the ground running
immediately gaining incremental sales momentum for Pharmagen so we
can quickly begin hiring field sales professionals to call across
and expand our customer base of hospitals, and physicians who
conduct in-office dispensing of non-script pharmaceuticals as well
as prescription based referrals. I really want to thank
Tim Tolan who sourced a strong field
of candidates which we are continuing to consider as we build a
professional sales capacity and especially for bringing Fred to
Pharmagen."
Commenting on his new role, Mr. Mundt stated, "This is a very
exciting time to be joining Pharmagen as they are poised for
growth. The executive team is taking all of the necessary steps to
be the leader in specialty drug, compounding and admix delivery.
This is a great opportunity for me to leverage my experience
building and developing commercial sales teams and to drive
incremental sales growth for company. Joining the leadership team
is truly an honor and I look forward to our bright future."
About Pharmagen
Pharmagen, Inc. ("Pharmagen"), and wholly owned subsidiaries and
operating divisions Pharmagen Laboratories, Inc., Pharmagen
Distribution, LLC and Pharmagen Nutraceuticals, Inc. offers
innovative solutions to the nations sterile pharmaceutical crisis.
With a multi-solution approach, Pharmagen is helping to meet
the demand of the health provider market through independent
wholesale, compounding, and IT solutions. Nationally focused,
Pharmagen is a distributor of specialty drugs, compounding and
admix pharmacy and producer of over-the-counter ("OTC") branded
multivitamins. Pharmagen currently functions as a
just-in-time source of supply for hospitals for those products that
are hard-to-find.
Contact: 888-264-4597 or info@pharmagenrx.com
Follow Us on Twitter: @pharmagenrx or
The Drug Shortage Report
http://drugshortagereport.blogspot.com/
Safe Harbor Statement
Information in this document constitute forward-looking
statements or statements which may be deemed or construed to be
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. The words
"forecast", "anticipate", "estimate", "project", "intend",
"expect", "should", "believe", and similar expressions are intended
to identify forward-looking statements. These forward-looking
statements involve, and are subject to known and unknown risks,
uncertainties and other factors which could cause Pharmagen actual
results, performance (financial or operating) or achievements to
differ from the future results, performance (financial or
operating) or achievements expressed or implied by such
forward-looking statements. The risks, uncertainties and
other factors are more fully discussed in Pharmagen's filings with
the U.S. Securities and Exchange Commission. All
forward-looking statements attributable to Pharmagen herein are
expressly qualified in their entirety by the above-mentioned
cautionary statement. Pharmagen disclaims any obligation to
update forward-looking statements contained in this estimate,
except as may be required by law.
SOURCE Pharmagen, Inc.